MAHON PAUL A Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
300
Insider Sells Sum
$171.78M

Insider Activity of MAHON PAUL A

According to the SEC Form 4 filings, MAHON PAUL A, being in a position of

  1. EVP & GENERAL COUNSEL at United Therapeutics Corporation,
    оver the last 12 months, has bought 0 shares, and sold 213125 shares for $110.54M,
    over all time since 2004-04-01, has bought 0 shares, and sold 1880209 shares for $331.83M.

Biography of MAHON PAUL A

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $110,544,72325100

Comparison of Insiders on Amount of Buys and Sells

2026-10-15SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0195%
$544.30$4.52M+8.49%
2026-10-01SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0193%
$564.95$4.69M-3.72%
2026-09-17SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0196%
$497.54$4.13M+9.23%
2026-09-03SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0192%
$482.03$4M+10.31%
2026-08-20SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0196%
$523.14$4.34M+0.43%
2026-08-06SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.019%
$517.05$4.29M-2.73%
2026-07-16SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0196%
$533.69$4.43M-0.82%
2026-07-02SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0197%
$552.56$4.59M-5.03%
2026-06-18SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0192%
$541.55$4.49M-1.35%
2026-06-04SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0195%
$547.07$4.54M-2.69%
2026-05-21SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0195%
$562.82$4.67M-5.26%
2026-05-07SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0186%
$586.75$4.87M-5.12%
2026-04-16SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0189%
$576.82$4.79M-6.44%
2026-04-02SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0188%
$565.87$4.7M-3.6%
2026-04-02SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
3,125
0.007%
$562.87$1.76M-3.6%
2026-03-19SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.019%
$529.95$4.4M+3.27%
2026-03-05SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0189%
$483.16$4.01M+11.93%
2026-02-19SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0184%
$476.34$3.95M+12.71%
2026-02-05SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0185%
$483.25$4.01M+12.76%
2026-01-15SaleUnited Therapeutics Corporation
UTHR
EVP & GENERAL COUNSEL
8,300
0.0185%
$469.89$3.9M+13.52%
Total: 338
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.